Skip to main content

3,5,7-trimethyl-1-(2-morpholin-2-ylethyl)-3H-azepin-2-one

ADVERTISEMENT
Identification
Molecular formula
C15H26N2O2
CAS number
58932-41-3
IUPAC name
3,5,7-trimethyl-1-(2-morpholin-2-ylethyl)-3H-azepin-2-one
State
State

At room temperature, this compound is a solid. Its physical state facilitates its storage and handling in laboratory settings.

Melting point (Celsius)
152.00
Melting point (Kelvin)
425.15
Boiling point (Celsius)
376.00
Boiling point (Kelvin)
649.15
General information
Molecular weight
264.36g/mol
Molar mass
264.3630g/mol
Density
1.2500g/cm3
Appearence

This compound typically appears as a crystalline solid. The coloration ranges from white to off-white, depending on the purity of the sample. It may also appear as a powder in its processed forms for various uses in chemical synthesis.

Comment on solubility

Solubility of 3,5,7-trimethyl-1-(2-morpholin-2-ylethyl)-3H-azepin-2-one

The solubility of the compound 3,5,7-trimethyl-1-(2-morpholin-2-ylethyl)-3H-azepin-2-one can be intricately analyzed due to its structural characteristics. This compound exhibits a unique profile attributed to the presence of the morpholine group and multiple methyl substituents. Below are some key points regarding its solubility:

  • Polar vs. Non-Polar: The presence of the morpholine moiety tends to increase the polarity of the overall compound, potentially enhancing its solubility in polar solvents such as water or alcohols.
  • Solvent Compatibility: It is expected to be more soluble in organic solvents like dimethyl sulfoxide (DMSO) and dimethylformamide (DMF), which can solvate larger, more complex molecules effectively.
  • Temperature Dependence: As with many organic compounds, solubility can be temperature-dependent, where increased temperatures may improve solubility due to enhanced molecular movement.
  • Interactions: Hydrogen bonding and dipole-dipole interactions between solute and solvent can significantly affect solubility. This compound's capabilities for such interactions must be assessed for specific solvents.

In summary, while predicting the exact solubility parameters of 3,5,7-trimethyl-1-(2-morpholin-2-ylethyl)-3H-azepin-2-one may require experimental evaluation, understanding its structural attributes can provide valuable insights into its solubility behavior. As always, the context of use and environmental conditions will greatly influence the solubility profile of this compound.

Interesting facts

Interesting Facts About 3,5,7-Trimethyl-1-(2-morpholin-2-ylethyl)-3H-azepin-2-one

The compound known as 3,5,7-trimethyl-1-(2-morpholin-2-ylethyl)-3H-azepin-2-one is a fascinating example of a complex organic molecule with unique characteristics and potential applications.

Structural Features

  • Azepin Structure: This compound features a seven-membered ring (azepine), which contributes to its structural diversity and reactivity.
  • Morpholine Group: The presence of a morpholine moiety not only enhances its solubility but may also influence its biological activity.
  • Trimethyl Substitution: The three methyl groups on the azepine ring can significantly impact the compound's steric and electronic properties.

Potential Applications

  • Pharmaceutical Development: Due to its complex structure, this compound could be investigated for its potential use in drug discovery and development.
  • Biological Activity: Compounds with similar structures have been noted for their ability to interact with biological systems, potentially leading to therapeutic applications.

Fun Facts

  • This compound can be synthesized through various organic reactions, making it an interesting case study for synthetic organic chemistry.
  • It showcases how small changes in molecular structure can lead to differences in biological and chemical properties, a core concept in medicinal chemistry.

In conclusion, 3,5,7-trimethyl-1-(2-morpholin-2-ylethyl)-3H-azepin-2-one illustrates the intricate nature of organic compounds and their potential applications, emphasizing the ever-evolving landscape of chemical research.